Navigation Links
Drug Coated Stents Under the Scanner

Drug-coated stents are minute coils implanted in the artery that gradually releases a medicine to ensure the artery does not clog again. It is estimated that drug-coated// stents have indeed saved the lives of more than six million people in the world.

Drug coated stents were not doubted for their safety till news regarding the development of potentially harmful clots did the rounds. Doctors opine, that if a patient discontinues Plavix, an anti-clotting medication, then he carries an enhanced risk of developing these life threatening blood clots. Yet, it is still unclear if the drug, Plavix, is safe to consume long term for stent patients.

According to some doctors, the risk is not always detrimental, because an approximate 5 clots are found in every 1000 drug coated stent patients. An FDA panel is due to meet soon, to thrash out existing doubts. Patients with stents have been advised not to discontinue their medication without the advice of medical specialists.
'"/>




Page: 1

Related medicine news :

1. Failure of Drug-Coated Stent
2. Drug-Coated Stent
3. Stronger Backing for Drug-Coated Stents
4. Drug-Coated Stents – Proven to be More Effectiv
5. Drug-Coated Stents Work Better In Diabetic Patients After Angioplasty
6. Vitamin E-Coated Dialysis Filters Help Fight Anemia in Hemodialysis Patients
7. Stronger Backing for Drug-Coated Stents
8. Drug-Coated Stents – Proven to be More Effectiv
9. The Efficacy Of Newer Stents Questioned
10. Analyzing The Side Effects Of Sirolimus Stents
11. Stents That Release Medication To Check Artery Narrowing
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Drug Coated Stents Under the Scanner

Breaking Medicine News(10 mins):Health News:American Diversified Holdings Corporation Announces Stem Cell Patent Acquisition Program 2Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 2Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 3Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 4Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 5Health News:BHR Pharma Files Investigational New Drug Application, Receives Orphan Drug Designation, for Traumatic Brain Injury Treatment 2Health News:The Breema Center Presents a Yearlong Campaign to Transform Stress into Harmony in 2010 and Beyond 2Health News:LCA-Vision Joins Forces With the Wounded Warrior Project to Give the Gift of Enhanced Vision to Wounded American Heroes 2
Breaking Medicine Technology:Royalty Pharma Announces that Alexander von Perfall Joins Management Team 2Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 37 Proven Steps 3A How to Defeat Stress Without Going Through the Embarrassment of Counseling 3A Proven Ways to Defeat Stress 49176 17 Proven Steps 3A How to Defeat Stress Without Going Through the Embarrassment of Counseling 3A Proven Ways to Defeat Stress 49176 27 Proven Steps 3A How to Defeat Stress Without Going Through the Embarrassment of Counseling 3A Proven Ways to Defeat Stress 49176 3iMedica Selected by NJ Physicians as Preferred EHR Vendor 49173 1iMedica Selected by NJ Physicians as Preferred EHR Vendor 49173 2Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 1Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 2Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 3Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 4Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 5Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 6Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 7Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 8Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 9Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 10